T. Rowe Price Associates’s ModivCare MODV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-33,813
| Closed | -$106K | – | 3090 |
|
|
2025
Q2 | $106K | Buy |
33,813
+20,543
| +155% | +$37.8K | ﹤0.01% | 2882 |
|
|
2025
Q1 | $18K | Sell |
13,270
-8,000
| -38% | -$38.7K | ﹤0.01% | 3010 |
|
|
2024
Q4 | $252K | Buy |
21,270
+787
| +4% | +$12.5K | ﹤0.01% | 2587 |
|
|
2024
Q3 | $293K | Hold |
20,483
| – | – | ﹤0.01% | 2488 |
|
|
2024
Q2 | $538K | Hold |
20,483
| – | – | ﹤0.01% | 2167 |
|
|
2024
Q1 | $481K | Buy |
20,483
+608
| +3% | +$22.3K | ﹤0.01% | 2227 |
|
|
2023
Q4 | $875K | Sell |
19,875
-3,541
| -15% | -$140K | ﹤0.01% | 1930 |
|
|
2023
Q3 | $738K | Sell |
23,416
-79,776
| -77% | -$3.12M | ﹤0.01% | 1934 |
|
|
2023
Q2 | $4.67M | Sell |
103,192
-15,729
| -13% | -$935K | ﹤0.01% | 1205 |
|
|
2023
Q1 | $10M | Sell |
118,921
-13,455
| -10% | -$1.29M | ﹤0.01% | 1053 |
|
|
2022
Q4 | $11.9M | Sell |
132,376
-34,394
| -21% | -$3.07M | ﹤0.01% | 1023 |
|
|
2022
Q3 | $16.6M | Sell |
166,770
-641,271
| -79% | -$66.4M | ﹤0.01% | 961 |
|
|
2022
Q2 | $68.3M | Buy |
808,041
+4,361
| +0.5% | +$440K | 0.01% | 784 |
|
|
2022
Q1 | $92.7M | Sell |
803,680
-824
| -0.1% | -$95.1K | 0.01% | 753 |
|
|
2021
Q4 | $119M | Sell |
804,504
-19,486
| -2% | -$3.01M | 0.01% | 711 |
|
|
2021
Q3 | $150M | Sell |
823,990
-8,885
| -1% | -$1.58M | 0.01% | 638 |
|
|
2021
Q2 | $142M | Sell |
832,875
-1,646
| -0.2% | -$247K | 0.01% | 665 |
|
|
2021
Q1 | $124M | Buy |
834,521
+139,879
| +20% | +$21.7M | 0.01% | 705 |
|
|
2020
Q4 | $96.3M | Sell |
694,642
-27,428
| -4% | -$3.4M | 0.01% | 738 |
|
|
2020
Q3 | $67.1M | Sell |
722,070
-3,090
| -0.4% | -$267K | 0.01% | 776 |
|
|
2020
Q2 | $57.2M | Buy |
725,160
+297,613
| +70% | +$20.1M | 0.01% | 805 |
|
|
2020
Q1 | $23.5M | Buy |
427,547
+406,409
| +1,923% | +$25.1M | ﹤0.01% | 1016 |
|
|
2019
Q4 | $1.25M | Sell |
21,138
-2,215
| -9% | -$135K | ﹤0.01% | 1802 |
|
|
2019
Q3 | $1.39M | Buy |
23,353
+57
| +0.2% | +$3.25K | ﹤0.01% | 1679 |
|
|
2019
Q2 | $1.34M | Sell |
23,296
-1,265
| -5% | -$82K | ﹤0.01% | 1725 |
|
|
2019
Q1 | $1.64M | Buy |
24,561
+30
| +0.1% | +$1.97K | ﹤0.01% | 1651 |
|
|
2018
Q4 | $1.47M | Buy |
24,531
+9,699
| +65% | +$643K | ﹤0.01% | 1651 |
|
|
2018
Q3 | $998K | Buy |
14,832
+1,268
| +9% | +$88.1K | ﹤0.01% | 1878 |
|
|
2018
Q2 | $1.06M | Buy |
13,564
+16
| +0.1% | +$1.2K | ﹤0.01% | 1812 |
|
|
2018
Q1 | $937K | Buy |
13,548
+22
| +0.2% | +$1.44K | ﹤0.01% | 1817 |
|
|
2017
Q4 | $803K | Sell |
13,526
-10
| -0.1% | -$566 | ﹤0.01% | 1890 |
|
|
2017
Q3 | $732K | Hold |
13,536
| – | – | ﹤0.01% | 1923 |
|
|
2017
Q2 | $685K | Hold |
13,536
| – | – | ﹤0.01% | 1936 |
|
|
2017
Q1 | $602K | Sell |
13,536
-4
| -0% | -$164 | ﹤0.01% | 1986 |
|
|
2016
Q4 | $515K | Hold |
13,540
| – | – | ﹤0.01% | 2026 |
|
|
2016
Q3 | $658K | Buy |
13,540
+6,900
| +104% | +$324K | ﹤0.01% | 1905 |
|
|
2016
Q2 | $298K | Hold |
6,640
| – | – | ﹤0.01% | 2171 |
|
|
2016
Q1 | $339K | Buy |
+6,640
| New | +$311K | ﹤0.01% | 2116 |
|
Other funds holding MODV
SHIM
RA
CG
FFA
T. Rowe Price Associates's MODV Position: Q3 2025 in Review
T. Rowe Price Associates sold out of ModivCare (MODV) in Q3 2025, closing a stake of 33,813 shares — an estimated $106K sold.
T. Rowe Price Associates first reported a position in MODV in Q1 2016 and held it in 38 quarters. The position peaked at $150M in Q3 2021. 13 funds tracked by Wall St. Rank hold MODV as of Q3 2025.
- T. Rowe Price Associates reported no remaining ModivCare position as of Q3 2025 after selling out during the quarter.
- T. Rowe Price Associates sold 33,813 ModivCare shares in Q3 2025, an estimated $106K.
- T. Rowe Price Associates first reported a position in ModivCare in Q1 2016 and held it in 38 quarters.
- T. Rowe Price Associates's ModivCare position peaked at $150M in Q3 2021.
- 13 funds tracked by Wall St. Rank held ModivCare as of Q3 2025.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.